Immuneering Corp IMRX
- atebimetinib — Pancreatic Ductal Adenocarcinoma Phase 3
- atebimetinib — Non-Small Cell Lung Cancer
- atebimetinib — Melanoma Phase 1
KSR (1 companies · 3 programs)
Companies with an active program directed at KSR.
Companies with an active program directed at KSR.